Cargando…
β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease
Alzheimer’s disease (AD) and vascular dementia are responsible for up to 90% of dementia cases. According to the World Health Organization (WHO), a staggering number of 35.6 million people are currently diagnosed with dementia. Blocking disease progression or preventing AD altogether is desirable fo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104928/ https://www.ncbi.nlm.nih.gov/pubmed/25100992 http://dx.doi.org/10.3389/fnagi.2014.00165 |